Table:
begin	end	state
1	33	cytoplasmic
34	55	transmembrane
56	114	non-cytoplasmic
115	133	transmembrane
134	139	cytoplasmic
140	165	transmembrane
166	171	non-cytoplasmic
172	199	transmembrane
200	218	cytoplasmic
219	239	transmembrane
240	250	non-cytoplasmic
251	268	transmembrane
269	304	cytoplasmic
305	316	transmembrane
317	320	cytoplasmic
321	339	transmembrane
340	350	non-cytoplasmic
351	371	transmembrane
372	385	cytoplasmic

Input:
>WP_094506904.1 NCBI__GCF_002252445.1:WP_094506904.1
MENADLQYVRSQMVDGEKPPRSVQGLSHWLRVNLFATPVDAALTIFGLAVVAWFLPPIIE
WLFINAAWTGTDRTACLTVAQGGVQPEGWSGACWAFVNAKYQQFIYGRYPLDERWRVDLT
AVLFVALLVPLLIPKVPHKVINAILFFFVFPVVAFFLLVGGSFGLRYVETALWGGLLVTL
VLSFVGIAVSLPLGIVLALGRRSKLPVIKTLSIMFIEMVRGVPLVTVLFMASVMLPLFLP
PGVTFDKLMRALIGVALFASAYMAEVVRGGLQAIPRGQYEGADALGLSYWHKTGLIILPQ
ALKLVIPGIVNTFIGLFKDTSLVYIIGMFDLLGIVRQNFSDANWASPQTPATGLIFAGFV
FWIFCFAMSRYSIFMERRLDTGHKR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server